Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine add-on therapy for schizophrenia
2012-005513-40Phase 2Terminated
- Sponsor
- Department of Psychiatry, Helsinki University Hospital
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing Famotidine add-on with Placebo add-on (2 arms). Primary endpoint: Positive and Negative Syndrome Scale (PANSS). Started Apr 2013; status: terminated.
02
Drugs
famotidine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2012-005513-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005513-40.